SelfDecode vs GlycanAge: Genetic Risk Scores vs Measuring Your Current Biology

Genetic risk scores and current biological measurements answer two different questions, and confusing them is the most common mistake in biological age testing. A DNA-based platform like SelfDecode reports your inherited genetic potential, fixed at birth, while GlycanAge measures your active, current level of chronic inflammation, the biology that actually drives how fast you are aging right now. For related background on how different biological age tests compare, see our epigenetic vs. glycan clock comparison.

This article answers the questions people most often ask when deciding between a genetic risk test and a current-biology biomarker like GlycanAge, including how the two interact, which one to trust for tracking an intervention, and how to use them together.

What is the core difference between a genetic risk score and GlycanAge?

A genetic risk score reports fixed, inherited probability; GlycanAge reports active, present-day inflammatory biology. A DNA test like SelfDecode tells you about genetic potential set at birth, but it cannot tell you whether your current habits or treatments are changing your biology.

"Genetic risk is genetic risk — whatever you do, you have the same genetic risk. Glycans enrich that picture, because they're genetically encoded too, plus everything you've done to yourself over the last decade or so."

— Prof. Gordan Lauc, Professor of Biochemistry and Molecular Biology, University of Zagreb, and Co-Founder & Chief Scientific Officer, GlycanAge

This is where GlycanAge works differently, looking specifically through the lens of the immune system to uncover the chronic inflammation that sits at the center of age-related disease, genetics, and lifestyle impact combined. If you want to know whether what you are doing today is working, a genetic risk score cannot tell you. Track your current inflammatory biology instead.

Why can't a DNA test tell me if my lifestyle or treatment is working?

Genetic risk scores are static by design; they describe potential, not present-state biology, so they cannot register change after a lifestyle shift, a new medication, or hormone therapy. This is precisely what separates genetics from glycans. Glycans, the complex sugars that coat antibodies and regulate immune signaling, integrate your genetic starting point with everything that has happened to your biology since. This combination, original risk plus everything that has happened since, is what makes a glycan-based test suited to answering whether something is working, not just what you were predisposed to.

If I've already done a DNA test, is there any point doing GlycanAge too?

Yes. If you have already tested your genes, a glycan-based test is the logical next step to see what that genetic potential actually looks like in practice, years of lifestyle, stress, hormones, and illness later. Genetic data tells you where you started. Your GlycanAge result tells you where you stand today and whether you are moving in a better or worse direction. Treat your DNA result as a starting reference, not a verdict, and pair it with a current biological age reading to get the fuller picture.

How is GlycanAge different from epigenetic clocks, if both claim to measure biological age?

Epigenetic clocks and GlycanAge measure biological age through different biological substrates, and neither is interchangeable with a genetic risk score. Both methylation clocks and GlycanAge meet the criteria for a valid biological age biomarker; they differ in which biological process they use as the measurement substrate.

"As we get increasingly accurate predictors of chronological age, how is this still a biomarker of aging, or is it just a predictor of somebody's calendar age?"

— Prof. Riccardo Marioni, Professor of Molecular Epidemiology of Aging, University of Edinburgh

Methylation clocks are best suited to understanding long-term epigenetic aging patterns and mortality risk stratification in epidemiological contexts, while GlycanAge is best suited to measuring current immune aging and chronic inflammation, tracking whether interventions are working, and providing a stable, reproducible biological age score that changes meaningfully when health changes. Crucially, glycan markers have been shown to change up to 10 years in advance of disease symptoms, providing a window for intervention that epigenetic clocks, with their slower response and higher measurement noise, cannot reliably offer. If your priority is seeing whether an intervention is shifting your biology within a practical timeframe, GlycanAge is built for that question; a genetic risk score was never designed to answer it at all.

Can glycans really capture lifestyle, stress, and medical interventions in a single number?

Yes, because glycans sit downstream of genetics, integrating what your genes set up with what you have actually lived through. Since glycans integrate genetic, epigenetic, and environmental factors into a single measurable signal, they capture the cumulative effect of lifestyle, hormones, stress, and medical interventions in a way that neither genes nor methylation patterns alone can reflect.

Does GlycanAge replace the need for a genetic test, or should I use both?

GlycanAge does not replace genetic testing; it adds the layer that genetics alone cannot provide. If you have already done a methylation clock test, GlycanAge adds the inflammatory and immune-aging layer that methylation alone cannot provide, and the same logic extends to genetic risk testing. A DNA report gives you fixed, lifelong risk categories. Your GlycanAge result gives you a moving number that reflects what you are doing about that risk in real time. Used together, a genetic test frames your predisposition and GlycanAge tracks whether your actions are changing the outcome.

How often should I retest with GlycanAge if I'm tracking a specific intervention?

Retest timing depends on what you are tracking, not on a fixed annual calendar. For pharmaceutical interventions, including HRT and medications with documented effects on glycan biology, retest at 3–4 months. For lifestyle interventions, such as dietary change, structured exercise, improved sleep, stress reduction, allow 6–12 months for the biology to reflect genuine remodeling. A single result tells you where you are relative to your chronological age peers. Repeated measurements tell you whether you are moving in the right direction and at what rate. Start by establishing a baseline before you change anything, then retest on the interval that matches your specific intervention rather than retesting too early and misreading noise as failure.

Is GlycanAge a diagnostic test, and should I use it instead of seeing a doctor?

No — aging itself is not classified as a disease, so no biological age test, genetic or glycan-based, replaces clinical diagnosis. This result falls under longevity diagnostics: it offers insight into potential health risks and areas worth addressing, rather than a traditional diagnosis. Use your result, alongside your genetic data and your clinician's input, to decide where to focus attention and which interventions to test, not as a standalone medical verdict.

Genetic risk scores tell you what you were handed at birth. Your GlycanAge result tells you what your biology is doing with it today, and whether your interventions are actually working on the inflammation that drives age-related disease. If you have already mapped your genetic risk and want to see your current biological age, order a GlycanAge test kit and self-book your 1:1 Result Interpretation Call with a longevity specialist to walk through your results.

External sources

• Krištić J, Vučković F, Menni C, Klarić L, Keser T, Bečeheli I, et al. Glycans are a novel biomarker of chronological and biological age. J Gerontol A Biol Sci Med Sci. 2014;69(7):779-89. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4049143/

• Lauc G. Role of glycans in longevity with Prof. Gordan Lauc [podcast, Internet]. The Age of You. Available from: https://glycanage.com/podcast/the-age-of-you/role-of-glycans-in-longevity-with-prof-gordan-lauc